MustGrow Biologics Corp.
MGROF
$0.49
-$0.01-2.96%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,106.26% | -648.88% | -569.42% | 95.26% | 91.73% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.44% | 49.37% | 56.11% | 122.77% | -31.87% |
| Change in Net Operating Assets | -119.60% | -246.18% | 67.06% | -275.49% | -203.31% |
| Cash from Operations | -2,525.69% | -1,613.04% | -987.83% | 90.97% | 94.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 97.64% | -- | -- | -- | -- |
| Issuance of Common Stock | 37.16% | -- | -- | -100.00% | -39.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,902.00% | 2,174.23% | -347.06% | -347.06% | -186.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -701.89% | -1,400.22% | -1,549.76% | 84.44% | 89.76% |